🟢 CLRO is trading 27.6% up today as legal probe adds to Cortigent merger momentum

CLRO is trading 27.6% up today at $8.93 as a legal investigation into its merger with Cortigent fuels further speculative volatility.

• The stock continues to react to a transformative reverse merger with Vivani’s neurostimulation subsidiary, which will result in the company rebranding as Cortigent Holdings on the Nasdaq.
• Recent gains are tied to heightened attention from a Halper Sadeh LLC investigation into whether the merger terms and board actions are fair to shareholders.
• The combination of the rebranding event and legal-risk headlines has generated significant event-driven momentum for the stock.